DiaMedica Therapeutics Inc (DMAC)
Press Release: DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program
Press Release: DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program
TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
Nightfood Holdings Inc. (OTCQB: NGTF) Becoming Key Player in AI Infrastructure, Advanced Computing Ecosystem Sectors
MMA Terminates Equity Line of Credit, Confirms No Drawdowns Occurred from the Facility
AmpliTech Group Strengthens ORAN 5G Growth Strategy with Addition of Two Senior Business Development Leaders
TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer’s Disease
GeneDx Names Mark Gardner President to Lead Its Next Phase of Scale and Growth
McGraw Hill, Inc. to Participate in an Investor Call Hosted by Macquarie
Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry